Eased Tariff Impact Fails To Lift Abbott As Outlook Cut Disappoints Investors

benzinga.com/markets/earnings/25/07/46470411/eased-tariff-impact-fails-to-lift-abbott-as-outlook-cut-disappoints-investors

Abbott Laboratories (NYSE:ABT) reported better-than-expected sales and profits in the second quarter, but the stock still plummeted nearly 10% after management dialed back earnings and growth projections for the rest of the year.
The company reported second-quarter sales of $11.14…

This story appeared on benzinga.com, 2025-07-17 14:48:15.
The Entire Business World on a Single Page. Free to Use →